Primary ovarian insufficiency was associated with a higher risk for autoimmune conditions including hypothyroidism and adrenal insufficiency.

The USPSTF recommends osteoporosis screening to prevent osteoporotic fractures for all women aged 65 years and older.

Heterozygous FMF can be monitored using S100A8/A9 and S100A12 levels, with colchicine discontinuation possible among patients with this genotype.

According to a recent study, there seems to be no association between hormone therapy and glioma risk among United States women.

According to a recent study, most children with multisystem inflammatory syndrome in children recover quickly.

The use of short-term hormone therapy for menopause is not associated with long-term cognitive impact after 10 years.

According to a recent study, the lifetime risk of dementia in a community-based cohort is 42 percent after age 55 years.

Despite the recent rise in herbal supplement use, research suggests certain supplements may pose risks for patients with ...

Below is a review of novel drug and biological products approved by the Food and Drug Administration (FDA) in 2024. The list includes several groundbreaking therapies that are expected to change the ...

Discrepancies in causes of death were found when reviewing medical records vs death certificate data among patients with AAV.

Mistrust in health care and government may largely explain COVID-19 vaccine hesitancy among Black women in the United States.

Some maternal medications, like SSRIs and steroids, are associated with lower levels of protein and fat in breastmilk.